DEF 14A Filing

Company

Eloxx Pharmaceuticals, Inc.

Filed

October 29, 2001

Period of Report

November 29, 2001

Accession Number

0000903100-01-500175

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →